BioCentury
ARTICLE | Clinical News

AMLprofiler regulatory update

March 21, 2011 7:00 AM UTC

Skyline received CE mark approval in the EU for its AMLprofiler microarray in vitro diagnostic for acute myelogenous leukemia (AML). Skyline has already launched the test, which uses nucelophosmin ( N...